Chiara Vaccaro

Chiara Vaccaro

Auto-generated profile, based on publicly available information

Chiara Vaccaro

Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Therapeutic Advances in Urology
Verified
Journal Article
Open access
PDF file
ABAndrea Benelli
Andrea Benelli
CVChiara Vaccaro
Chiara Vaccaro
SGSonia Guzzo
Sonia Guzzo
CNCarlotta Nedbal
Carlotta Nedbal
VVVirginia Varca
Virginia Varca
AGAndrea Gregori
Andrea Gregori
Background: The aim of this work is to evaluate the detection rate of magnetic resonance imaging/transrectal ultrasound (MRI/TRUS) fusion-guided biopsy for clinically significant prostate cancers (Cs PCas), with particular interest in biopsy-naive patients and patients in active surveillance. MRI-targeted biopsy improves cancer detection rate (DR) in patients with prior negative biopsies; the current literature focuses on biopsy naive patients. We also evaluated the pathologic concordance between biopsies and surgical specimens. Methods: MRI/TRUS fusion-guided biopsies were performed between February 2016 and February 2019. Patients with previous negative biopsies, biopsy-naive or in active surveillance (AS) were included. Cs PCas were defined through Epstein’s criteria. Results: A total of 416 men were enrolled. The overall DRs and Cs PCa DRs were 49% and 34.3%, respectively. Cs PCas were 17.2%, 44.9% and 73.4%, respectively for PI-RADS 3, 4 or 5. Among biopsy-naive patients, 34.8% were found to have a Cs PCa, while a 43.6% tumour upgrading was achieved in men with a low risk of PCa. In patients who underwent radical prostatectomy (RP), the concordance between biopsy Gleason score (GS) (bGS) and pathological GS (pGS) was 90.8%. Conclusion: Our study highlights the role of MRI/TRUS fusion prostate biopsy in the detection of PCa in patients with previous negative biopsies focusing on Cs PCa diagnosis. The MRI/TRUS fusion biopsy is also emerging as a diagnostic tool in biopsy-naïve patients and deserves a fundamental role in AS protocols. A greater concordance between bGS and pGS can be achieved with targeted biopsies.

13 December 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CVChiara Vaccaro
Chiara Vaccaro
VLVito Lorusso
Vito Lorusso
FPFranco Palmisano
Franco Palmisano
MRMarco Rosso
Marco Rosso
MNMassimiliano Nicola
Massimiliano Nicola
MTMichele Talso
Michele Talso
The invention of the flexible ureteroscope (fURS) and its subsequent spread have revolutionized the surgical management of urolithiasis and upper tract urothelial carcinoma (UTUC). During the last few years, single-use flexible ureteroscopes (su-fURSs) have been developed to improve the limitations of reusable fURSs, namely their cost, durability and risk of device contamination. Since the introduction of the first fully disposable digital fURS, several su-fURSs have been developed by various manufacturers. In this pictorial review, we combined the different physical and technical features of su-fURSs currently available on the market with Food and Drug Administration (FDA) and European Conformity (CE) approval, in order to help surgeons choose the appropriate device according to each case requirement and personal preferences. To the best of our knowledge, 17 su-fURSs with CE and FDA approval have been developed to date.

3 December 2018 in Urologia Journal
Verified
Journal Article
Closed access
ABAndrea Benelli
Andrea Benelli
VVVirginia Varca
Virginia Varca
CVChiara Vaccaro
Chiara Vaccaro
SGSonia Guzzo
Sonia Guzzo
MNMarta Nicola
Marta Nicola
FNFranca Di Nuovo
Franca Di Nuovo
Introduction: Bladder mucosa is anatomically covered by urothelial epithelium. The replacement of the urothelium with stratified squamous cells is defined as squamous metaplasia which can be keratinizing or non-keratinizing. Clinically, it is also known as leukoplakia or keratinizing cystitis of the bladder. Although several etiologic factors have been proposed such as chronic inflammation, irritative stimuli and infection, its pathogenesis is not clearly understood. The natural history of squamous metaplasia and clinical treatment are controversial. Many authors consider squamous metaplasia as a premalignant lesion, so it is fundamental to find an effective treatment to reduce the risk of developing bladder squamous carcinoma. Case description: We report our management of a 58-year-old man with histological evidence of keratinizing squamous metaplasia and severe lower urinary tract symptoms. After repeated transurethral resections, the patient was treated with intravesical instillation of hyaluronic acid showing the regression of the lesion with an improvement of macroscopic appearance followed by the resolution of clinical symptoms. Conclusion: The therapeutic management of keratinizing squamous metaplasia is controversial, and currently no effective medical therapy is available for its treatment. Actually, patients undergo transurethral resections and a multidisciplinary approach is required to avoid cystectomy. Annual cystoscopy with multiple biopsies should be performed to determine the presence of dysplasia. Moreover, the therapeutic treatment with hyaluronic acid instillations could be the starting point and the gold standard in the follow-up of our patient. However, at present, further studies are required to formulate an adequate policy for therapeutic management of this unusual lesion of the bladder mucosa.

24 June 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
ELElena Lievore
Elena Lievore
FMFrancesco Alessandro Mistretta
Francesco Alessandro Mistretta
MPMattia Luca Piccinelli
Mattia Luca Piccinelli
CVChiara Vaccaro
Chiara Vaccaro
MTMatteo Tallini
Matteo Tallini
GMGennaro Musi
Gennaro Musi

24 April 2025 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
CVChiara Vaccaro
Chiara Vaccaro
FMFrancesco Alessandro Mistretta
Francesco Alessandro Mistretta
MPMattia Luca Piccinelli
Mattia Luca Piccinelli
ELElena Lievore
Elena Lievore
LJLetizia Maria Ippolita Jannello
Letizia Maria Ippolita Jannello
GMGennaro Musi
Gennaro Musi

8 April 2024 in BJU International
Verified
Journal Article
Closed access
PDF file
CVChiara Vaccaro
Chiara Vaccaro
KDKarel Dewulf
Karel Dewulf
KRKonstantin Richter
Konstantin Richter
NBNicolas Branger
Nicolas Branger
SRStanislas Rybikowski
Stanislas Rybikowski
GPGeraldine Pignot
Geraldine Pignot